VUMC sources quoted in Wall Street Journal, New York Times, Washington Post, more

William Schaffner, MD, professor of Preventive Medicine, continues to be one of the most in-demand sources about COVID-19, influenza and other subjects in the news. Among the news organizations he has spoken with recently: The New York Times, CNN, Reuters, USA Today, Shape magazine Healthline.com, and Prevention magazine.

Keipp Talbot, MD, MPH, associate professor of Medicine, was quoted in a story in The Wall Street Journal about COVID vaccine distribution.

David Aronoff, MD, director of the Division of Infectious Diseases, was quoted in a Washington Post story about what went wrong with vaccine distribution in the U.S. He also spoke to the website  CreakyJoints.org for a story about what to do after getting the COVID-19 vaccine if you are immunocompromised or have an autoimmune condition.

A Medpage Today story, headlined Acute brain dysfunction prolonged in COVID-19 ICU patients, quotes Wesley Ely, MD, professor of Medicine, Allergy/Pulmonary & Critical Care Medicine.

Associated Press chief medical writer Marilynn Marchione interviewed Buddy Creech, MD, director of the Vanderbilt Vaccine Research Program, for a story about a new study from Rockefeller scientists on virus variants and vaccines.

Patients with type 1 diabetes should be given the same high priority for receiving the COVID-19 vaccine as are persons with type 2 diabetes, Alvin C. Powers, MD, director of the Division of Diabetes, Endocrinology and Metabolism; David Aronoff, MD, director of the Division of Infectious Diseases;  and collaborator Robert H. Eckel, MD, of the University of Colorado, argue in correspondence published by The Lancet Diabetes & Endocrinology.